UPA HCG 5000 I.U

UPA HCG 5000 I.U is a self-mix injectable hormone product listed as containing 5000 International Units (IU) of Human Chorionic Gonadotropin (hCG) per vial. HCG is a naturally occurring glycoprotein hormone primarily produced during pregnancy and plays an important role in reproductive hormone regulation.

Human Chorionic Gonadotropin has biological activity similar to luteinising hormone (LH), which is responsible for stimulating testosterone production in men and supporting reproductive processes in women.

HCG is used medically in certain fertility treatments and hormone-related conditions. It has also attracted interest in male reproductive health because of its ability to stimulate testosterone production through direct activation of LH receptors in the testes.

In bodybuilding communities, HCG is sometimes associated with post-cycle therapy (PCT) and the management of testosterone suppression following anabolic steroid use.

What UPA HCG Is Used For

Human Chorionic Gonadotropin is a reproductive hormone used in specific medical treatments involving fertility, testosterone production and reproductive function.

Its recognised medical applications and physiological effects include:

• Testosterone Production: Stimulates Leydig cells in the testes to produce testosterone through activation of LH receptors.
• Male Hypogonadotropic Hypogonadism: Used in selected men with insufficient gonadotropin stimulation to support testosterone production.
• Male Fertility Treatment: May be used as part of specialist treatment to support sperm production in certain forms of male infertility.
• Testicular Function: Stimulates hormonal activity within the testes, particularly testosterone synthesis.
• Ovulation Induction: Used in certain fertility treatment protocols to trigger final egg maturation and ovulation.
• Assisted Reproductive Treatment: May be prescribed as part of medically supervised fertility programmes.
• Cryptorchidism: Has historically been used in selected cases of undescended testes, although surgical management is generally preferred in current clinical practice.
• Reproductive Hormone Regulation: Mimics LH activity and influences hormone production in reproductive tissues.
• Post-Cycle Hormonal Recovery: Sometimes used off-label following anabolic steroid exposure, although its effectiveness and safety for this purpose have not been established through adequate clinical research.

Important: HCG is not an anabolic steroid. Its primary effects are associated with reproductive hormone stimulation rather than direct androgen receptor activation.

How UPA HCG Works

Human Chorionic Gonadotropin is a glycoprotein hormone that acts primarily by binding to luteinising hormone/chorionic gonadotropin receptors (LHCGR) in reproductive tissues.

In men, these receptors are found on Leydig cells within the testes. When activated, they stimulate intracellular signalling pathways involved in testosterone synthesis.

In women, HCG acts on LH receptors in the ovaries, supporting final follicular maturation, ovulation and corpus luteum function.

Its primary mechanisms include:

• LH Receptor Activation: Binds to luteinising hormone receptors, producing biological effects similar to natural LH.
• Testosterone Stimulation: Activates Leydig cells in the testes, increasing endogenous testosterone production.
• Steroidogenesis: Stimulates biochemical pathways involved in converting cholesterol into steroid hormones.
• Testicular Hormone Activity: Supports testosterone production within the testes.
• Sperm Production Support: May indirectly support spermatogenesis by maintaining intratesticular testosterone levels, although additional FSH treatment may be required in some patients.
• Ovulation Triggering: Mimics the natural LH surge involved in final egg maturation and ovulation.
• Corpus Luteum Activity: Supports progesterone production by the corpus luteum in certain reproductive circumstances.
• Reproductive Hormone Signalling: Influences hormonal pathways involved in fertility and reproductive function.

Unlike Selective Oestrogen Receptor Modulators (SERMs), such as Clomiphene, HCG does not primarily stimulate the hypothalamus or pituitary gland to release additional LH.

Instead, HCG acts directly on LH receptors, producing hormone-related effects in the testes and ovaries.

Possible Side Effects

Human Chorionic Gonadotropin may cause adverse effects associated with reproductive hormone stimulation, changes in testosterone and oestrogen levels, and individual sensitivity to hormone treatment.

Common or Recognised Side Effects:

• Headaches.
• Fatigue or general weakness.
• Irritability or mood changes.
• Restlessness.
• Nausea or gastrointestinal discomfort.
• Injection-site pain, redness or swelling.
• Mild fluid retention or bloating.
• Breast tenderness.
• Gynaecomastia in men.
• Acne or oily skin associated with hormonal changes.
• Changes in libido.
• Increased oestrogen levels in men.